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Abstract
Telephone-based disease management (DM) programs can improve health outcomes and provide a positive
return on investment to funders. However, there is scant evidence about how to use hospital admission episode
data to identify patients who are most likely to participate in a DM program. The objective of this study was to
use hospital admission episode data held by health insurers to determine those factors that predict members
with chronic disease joining and remaining in a DM program for at least 6 months. A multivariable logistic
regression model was constructed to determine predictors of participating in a DM program for an insured
population who had been admitted to hospital for congestive heart failure, coronary artery disease, or chronic
obstructive pulmonary disease. The outcome variable was binary: did the member both opt into the DM
program and remain in the program for at least 6 months? The study population included 9874 private health
fund members. Time from a related hospital admission was a significant predictor, with those offered the
program within 3 to 6 months being 71% more likely (95% confidence interval [CI]: 33%, 113%) to participate.
The length of time from offer to commencement also was a significant predictor, with those commencing within
3 to 4 months being 75% (95% CI: 44%, 112%) as likely to remain in the program. It is possible to predict which
individuals are most likely to participate in a telephone-based DM program using hospital admission episode
data. Once individuals are identified, timely commencement of a DM program is an important predictor of
success. (Population Health Management 2012;15:331–337)
Introduction
Disease management (DM) programs for people withchronic illness have become common practice in many
health care settings. Rising costs associated with the increas-
ing prevalence of chronic disease have provided an incentive
to curb the cost impact on health funders1 and encouraged the
search for relatively low-cost postdischarge interventions
aimed at improving the management of chronic disease in the
community setting. The positive impact of DM programs on
reducing health care episodes appears to be mediated by the
effect on disease progression1 of increasing the patients’
knowledge about and behavior modification toward day-to-
day management of their disease.2,3
In the United States, Medicare and Medicaid have been
investigating the success of chronic disease management for
their publicly insured members.4 In the private sector, in-
surers, managed care organizations, and employers1 have
been providing DM interventions to their members over the
last 2 decades.
Studies have shown that DM programs reduce hospital
admissions,3,5–8 length of stay,5–7 emergency room visits,5
hospital claims expense,7,9 and improve quality of life2,10 for
people with chronic disease. There is also evidence of im-
proved disease self-management,11 a positive return on
investment,12 and cost-effectiveness12,13 for people with
cardiac failure and diabetes.14 Programs that target multiple
chronic conditions also have found that the return on
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investment of providing DM programs to insured members
was positive for insurers.12
The advantage of telephone-based DM programs is that
the delivery is via technology that is accessible to a broad
range of the population across a large geographic area.15
Telephone-based interventions have been described as being
a moderate-intensity DM program with personal contact
made with the patient.16 A recent Cochrane Review of a
structured telephone support DM program for people with
chronic heart failure found that hospitalizations and costs
were reduced and people reported improved quality of life.17
When costs of delivery were included, 1 study found a net
savings of 10% in a telephone-based DM intervention for
heart failure.4 A recent randomized controlled trial (RCT) of
a telephone-based intervention also found that the inter-
vention group experienced lower mean values for total
claims and total costs (with intervention costs included)
compared to the control group.7 A telephone-based DM in-
tervention for people with diabetes with a follow-up period
of 18 months also found better control of diabetes.18
Despite evidence that DM programs can improve health
outcomes and provide a positive return on investment to
funders, there is little evidence about how to identify patients
prospectively who are most likely to participate and remain
in a DM program from hospital admission episode data.
Factors found to affect any self-reported participation in a
coronary artery disease (CAD) DM program included
age,5,19 diabetes as a comorbidity,19 time since last ‘‘heart
attack,’’19 higher than average utilization of health services
prior to entering the program,5 and severity of illness.5 The
importance of time since last ‘‘heart attack’’ in CAD19 sug-
gests that timing from a significant event might be relevant;
however, no other studies have explored the influence of
timing on participation in DM programs.
The lack of data to identify those patients most likely to
participate in DM programs from existing patient informa-
tion and billing systems is a potential obstacle to the broader
implementation of these programs.12,20 Health insurers and
public funders that cover a large population base have in-
tegrated information systems that hold patient administra-
tive and clinical information across different providers
within the health care system. These information systems
potentially enable the rapid identification of members who
are likely to participate in and benefit from DM programs.
This may be an important factor in reducing delivery costs
by increasing the efficiency of DM programs through tar-
geting individuals who are most likely to participate in the
programs.
The objective of this study was to identify the factors that
predict people with a chronic disease opting in and re-
maining in a telephone-based DM program for at least 6
months, using hospital admission episode data collected by
health care funders or insurers.
Methods
This was a prospective cohort study that formed part of a
larger RCT to estimate the return on investment of a tele-
phone-based DM program for chronic disease from the
perspective of a private insurer.7 Monash University Human
Research Ethics Committee granted approval for the study
(CF07/0288-2007000019).
Study population
Privately insured members of Medibank Private were in-
vited to participate in a chronic DM program for CAD,
congestive heart failure (CHF), or chronic obstructive pul-
monary disease (COPD). The cohort members were identi-
fied retrospectively from insurance claims between 2003 and
2009 as having had a hospital admission where CHF, CAD,
or COPD was identified as a primary (ie, reason for admis-
sion) or secondary (ie, comorbidity associated with the ad-
mission) diagnosis. They were then randomized to either
receive an invitation from Medibank Private to participate in
a telephone-based DM program, or they were put on a
waiting list to receive an invitation after 12 months. The DM
program was provided by McKesson Asia-Pacific, a separate
entity contracted by Medibank Private. Insured members
were able to opt out to Medibank Private or to the DM
provider prior to commencement or at any time after they
had started the program.
Data sources
Medibank Private provided the case-level data pertaining
to the diagnosis for hospital admissions leading up to the
offer to participate in the DM program, the date the program
was offered to each member, and demographic information
and insurance claims data for hospital admissions and an-
cillary health services over the 12-month period of the DM
program. McKesson Asia-Pacific provided case-level data
relating to the date the individual member commenced the
program, and the dates of 6- and 12-month assessments.
Data from each source were cleaned and matched according
to a unique identification number generated specifically for
the study.
Outcome measure
The binary outcome variable indicated whether the in-
sured member opted in and completed at least 6 months of
the DM program from the date they started the program.
Statistical methods
Multivariable logistic regression models were used to es-
timate odds ratios (OR) and coefficients for a range of ex-
planatory variables on the binary outcome. Statistical
software packages Stata/MP 11.0 for Windows (StataCorp
LP, College Station, TX) and IBM SPSS Statistics Version 19
(IBM, Chicago, IL) were used to analyze data. All confidence
intervals (CI) are 95%.
The authors fitted models of the form:
logit(in program for at least 6 months) = f(sex, age group,
disease group, hospital admissions over 12 months, time
from date of the related hospital admission to program offer
date, time from offer date to program start date).
Summary hospital admission variables for 15 months prior
to and 3 months up to the program offer date were deter-
mined from insurance claims data. This meant that the
3-month lag in insurance claims data could be accounted for,
while allowing a full 12-month picture of hospitalization to
eliminate potential confounders such as seasonal variation.
When a member did not have a claim for a hospital episode
the hospital admission variable was given a value of zero. The
variable was included in the model as a continuous variable.
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The time interval between the date of the most recent
related hospital admission and the DM program offer date
was obtained from insurance claims data provided by Medi-
bank Private. Six models were examined based on varying
definitions of the ‘‘related hospital admission,’’ including
whether it was an overnight or a same-day admission and
diagnostic information relating to the hospitalization. The
admission diagnosis was varied from strict criterion (the pri-
mary admission diagnosis based on International Classification
of Diseases, 10th Revision [ICD-10] was the same as the DM
program offered), to less strict criteria (any primary or sec-
ondary diagnosis based on ICD-10 could be the same as any
of the DM programs offered) and adjusted for overnight
admission only, or same-day as well as overnight. This vari-
able was divided into 7 categories, ranging from < 90 days to
more than 3 years, to reflect the number of days between the
related admission and offer date.
The time from date of program offer to commencement
date in days also was calculated to estimate the effect of
delayed entry on the risk of opting in and staying in the
DM program. This was included in the predictive model as
the insurer can have some control over the time interval
between the offer and start dates. This variable was
entered into the model as a categorical variable with 6
categories.
Results
Case numbers and model identification
There were 9874 eligible members with CAD, CHF, or
COPD identified from the insurance claims data. Data were
missing for 890 members (9%) of the 9874 eligible records.
Missing data related to start date or offer date. The re-
maining 8984 members were included in the models to
explore the best definition of related hospital admission.
The Wald chi-square test was used to assess the perfor-
mance of this factor in the model. Table 1 shows the case
numbers and Wald chi-square values for each of the 6
models. Model (2A) with the highest chi-square value
(v2 = 36.8 (6df), P < 0.001) was chosen for the multivariable
logistic regression.
Population characteristics
Twenty-six percent of the total sample of 8976 cases in
Model 2A enrolled and remained in the program for at least
6 months; the remaining 74% did not start the program at all
or ceased participation within 6 months of their start date.
Table 2 shows the age group, sex, and disease group ac-
cording to the risk of opting in and remaining in the DM
program for at least 6 months.
Multivariable logistic regression model
The multivariable logistic regression model results for
Model 2A are presented in Table 3. The results are expressed
as an OR; from these the size of the contribution of that risk
factor can be identified, controlling for other covariates in the
model. Most covariates were significant with the exception of
disease variables and sex. Table 3 also shows the reference
group for each covariate where there was more than 1 group.
Findings suggest that people younger than 50 years of age
were 40% less likely to remain in the program for 6 months
compared to those aged 60–69 years. People aged between
50–59 years were 23% less likely, and people older than 80
years of age were 27% less likely to remain in the program for
at least 6 months compared to people aged 60–69 years. We
can conclude that patients aged 60 to 79 years old are more
likely to remain in the program compared to other age groups.
Results for the time between the related hospital admis-
sion and the offer date were all significantly different com-
pared to the baseline group of 2–3 years, with the exception
of > 3 years. The results suggest that the best time to offer a
DM program is within 3–6 months of a related hospital ad-
mission. However, even if the individual is offered the pro-
gram between 6 and 12 months after the admission they still
will be at least 33% more likely to participate and remain in
the program compared to the baseline group. After 1 year,
the relative likelihood increase falls to 20%.
Results for the time between the program offer and the
actual commencement date were all statistically significant. If
the time between the offer date and the commencement date
is very short ( < 30 days) or very long (more than 6 months),
then people were less likely to remain in the program for
Table 1. Case Numbers and Varying Definitions of ‘‘Related Hospital Admission’’ for Each Model
Model Definition
Case
numbers v2 (6df) P value
Model 1A Primary diagnosis is the same as the DM program diagnosis offered to the
member for any admission (overnight or same day)
7928 25.5 < 0.001
Model 1B Primary diagnosis is the same as the DM program diagnosis offered to the
member for overnight admission only
7856 22.7 0.001
Model 2A Any diagnosis (primary or secondary) is the same as the DM program
diagnosis offered to the member for any admission (overnight or same day)
8976 36.8 < 0.001
Model 2B Any diagnosis (primary or secondary) is the same as the DM program
diagnosis offered to the member for overnight admission only
8904 31.9 < 0.001
Model 3A Any diagnosis (primary or secondary) is the same as any of the DM program
diagnoses1 for any admission (overnight or same day)
8984 25.2 < 0.001
Model 3B Any diagnosis (primary or secondary) is the same as any of the DM program
diagnoses1 for any admission for overnight admission only
8933 26.6 < 0.001
1DM program diagnoses included all of coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease.
DM, disease management.
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6 months. The results demonstrate that the optimal time
between the offer and commencement dates is 2–6 months,
with the optimum likely to be achieved if the person com-
mences within 3–4 months of the program offer.
The lagged variable for total hospital length of stay in the
12 months prior to the offer of a DM program was statisti-
cally significant, but the OR was close to 1 (0.994). Assuming
a linear relationship, the result can be interpreted as: for each
increase in length of stay by 1 day in the previous 12 months,
the individual is 1% less likely to remain in the program for 6
months. If this result is calculated as length of stay in months
instead of days, the OR can be recalculated as 0.84 (calcu-
lated as exp[30*log(0.9905784)] = 0.842), meaning that for
each increase in length of stay by 1 month within a 12-month
period there is a 16% decreased likelihood of remaining in a
DM program for at least 6 months.
The model can be used to predict a positive outcome of
program participation using known values of population
characteristics from the coefficients of the parameters gen-
erated from the model. Table 4 predicts the probability of
DM program participation using hypothetical values of
Table 2. Risk of Opting in and Remaining
in the Disease Management Programs
for At Least 6 Months
Population characteristic Risk 95% CI
Age Group
Age < 50 yrs 20% 15.6% 23.6%
Age group 50–59 yrs 24% 21.5% 25.9%
Age group 60–69 yrs 28% 26.7% 30.2%
Age group 70–79 yrs 29% 27.4% 30.6%
Age 80 + yrs 20% 18.3% 22.3%
Sex
Female 24% 22.8% 25.9%
Male 27% 25.7% 28.0%
DM Program
CAD 28% 26.7% 28.8%
CHF 21% 18.5% 23.0%
COPD 20% 17.3% 22.7%
CAD, cornary artery disease; CHF, congestive heart failure; CI,
confidence interval; COPD, chronic obstructive pulmonary disease;
DM, disease management.





Interval for OR P value Coefficient
Age Group
Age < 50 yrs 0.60 0.45 0.78 < 0.0001 - 0.52
Age 50–59 yrs 0.77 0.66 0.90 0.001 - 0.26
Age 60–69 yrs Reference Group
Age 70–79 yrs 1.11 0.98 1.25 0.087 0.10
Age 80 + yrs 0.73 0.63 0.86 < 0.0001 - 0.31
Sex
Male Reference Group
Female 0.96 0.86 1.07 0.456 - 0.04
Disease Group
CAD Reference Group
CHF 1.00 0.84 1.19 0.973 - 0.003
COPD 0.92 0.75 1.13 0.420 - 0.08
Total hospital length of stay in 12 months
using 3-month lag from offer date
0.99 0.99 1.00 0.000 - 0.005
Time from related hospital admission
to program offer (days)
< 90 days (< 3 months) 1.31 1.00 1.71 0.048 0.27
90–179 days (3–6 months) 1.71 1.33 2.13 < 0.0001 0.53
180–364 days (6–12 months) 1.33 1.14 1.54 < 0.0001 0.28
365–544 days (12–18 months) 1.20 1.03 1.40 0.019 0.19
545–729 days (18 months–2 yrs) 1.20 1.05 1.38 0.007 0.19
730–1094 days (2–3 yrs) Reference Group
> 1095 days (> 3 yrs) 0.88 0.73 1.06 0.188 - 0.13
Time from program offer
to commencement date (days)
< 30 days (1 month) 0.66 0.57 0.76 < 0.0001 - 0.41
30–59 days (1–2 months) Reference Group
60–89 days (2–3 months) 1.19 1.03 1.37 0.021 0.17
90–119 days (3–4 months) 1.75 1.44 2.12 < 0.0001 0.56
120–179 days (4–6 months) 1.59 1.33 1.90 < 0.0001 0.47
> 180 days (> 6 months) 0.49 0.39 0.63 < 0.0001 - 0.71
Constant < 0.0001 - 1.01
CAD, cornary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
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model parameters. For example, in the best-case scenario, a
male aged 70–79 years with CAD or CHF who is offered a
DM program within 3–6 months of a related hospital ad-
mission and commences within 3–4 months of the program
offer has a 54% probability of completing the program.
However, if commencement of the program is delayed by at
least 6 months, the probability of participation reduces to
25%. The worst-case scenario would give a female younger
than 50 years of age with COPD who is offered a program
more than 3 years after a related hospital admission and does
not commence the program for at least 6 months only a 7%
chance of opting in and completing the program.
Discussion
Insurers and funders can use the results presented in this
model to predict which individuals with a chronic disease
are likely to participate and remain in a telephone-based DM
program for at least 6 months. The results demonstrate that
people who are most likely to participate in DM programs
can be identified by health insurers or funders using ad-
ministrative data related to a hospital admission. Insurers
can then offer a DM program within a defined time from the
hospital admission to maximize participation.
The findings suggest an optimal time when people are
most receptive to joining the program. A period of time that
is either too close to or too distant from the relevant hospital
admission reduces adoption. Insurers or funders can use this
information to target individuals when they are most likely
to be receptive to participating in a DM program. Likewise,
once the offer has been made, there is an optimal time to
commence the program. Insurers can then use this infor-
mation to encourage participants to commence the program
within an optimal time period from offer, or include incen-
tives or penalties related to timing in contractual arrange-
ments with third-party providers.
The finding that hospitalization prior to the offer is sig-
nificant and supports results from other studies that also
have reported that severity of illness and an event such as a
heart attack are important predictors of participation in a
DM program.5,19 Severity of illness, however, is often diffi-
cult to determine from administrative data without sup-
porting clinical information. Total length of stay in a
preceding
12-month period may be a reasonable proxy for disease se-
verity and is easily determined from administrative data.
The use of findings from large population-based proba-
bility models to determine which individuals are most likely
to participate in DM programs has many advantages. In-
surers or public funders with large enrolled populations can
target people based on statistical probabilities from condi-
tion-based predictive models. The use of administrative data
at a population level means that all individuals meeting the
criteria can be offered the program; therefore, the decision to
offer is consistent and transparent. This is in contrast to
leaving the decision to individual clinicians where selection
bias is a potential issue. Clinicians may choose patients who
they believe will participate in and complete a program. It
also avoids the influence of other barriers or financial in-
centives faced by individual providers.21
The cost of targeting individual patients can be reduced by
using insurance data related to the hospital episode and a
computer algorithm that incorporates the broadest possible
evidence-based criteria. Funders can further realize econo-
mies of scale because they already have integrated infor-
mation systems in place, and rely on health care providers to
provide individual-level clinical and other administrative
data as part of the billing process. In addition, with large
enrolled populations, the funder can enter into contracts with
specialist DM providers, thereby achieving some efficiency
through a reduction in transaction costs.
This predictive model for participation in a telephone-
based DM program has several limitations. First, the DM
program participants were a privately insured population; it
is likely that non-privately insured patients might have dif-
ferent characteristics and predictors. Second, data were lim-
ited to those available to private insurers, predominantly
relating to hospital claims. Other data, such as demographic
characteristics and socioeconomic status of patients, were
not available. It is possible that demographic factors such
as race,22 income, household size, and education level
might be important predictors. Likewise, psychosocial issues
Table 4. Probability of Disease Management Program Participation Using Hypothetical Values













70–79 yrs M CAD 6 3–6 months 3–4 months 54%
70–79 yrs M CAD 6 3–6 months > 6 months 25%
70–79 yrs M CHF 6 3–6 months 3–4 months 54%
70–79 yrs F CAD 6 3–6 months 3–4 months 53%
70–79 yrs F CHF 30 3–6 months 3–4 months 50%
50–59 yrs M CAD 6 3–6 months 1–2 months 32%
50–59 yrs F CAD 6 3–6 months 1–2 months 31%
80 + yrs F CHF 6 3–6 months 1–2 months 30%
80 + yrs F CHF 6 12–18 months 1–2 months 23%
< 50 yrs F COPD 30 > 3 yrs > 6 months 7%
< 50 yrs F COPD 6 > 3 yrs > 6 months 7%
< 50 yrs F CAD 6 3–6 months 3–4 months 38%
< 50 yrs M CAD 6 3–6 months 3–4 months 39%
CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
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including dementia, behavioral health problems, and sub-
stance abuse may predict participation in a DM program, but
are not available from administrative data. This is likely to
limit the overall sensitivity of the model. Finally, the DM
program offered to members was a telephone-based pro-
gram; therefore, other factors that might have an impact on
participation include willingness to talk on the telephone,
capacity to communicate by telephone (eg, hearing impair-
ment, language barriers), and living circumstances (eg, living
alone, residential care).
The data were censored because the actual date of dropout
was unknown, only whether the individual had undergone a
6-month assessment. In the RCT, as well as undertaking an
intention to treat analysis, a per protocol evaluation was done
based on those who had participated in the program for at
least 6 months. The findings suggested a positive return on
investment to the insurer for the telephone-based interven-
tion.7 Based on this, a binary outcome variable was used in
the multivariate logistic regression model. However, whe-
ther 6-month participation is the ‘‘correct amount’’ is likely to
depend on a range of factors, such as the design and inten-
sity of the intervention. In conclusion, it is possible to predict
which individuals are most likely to participate and remain
in a telephone-based DM program using hospital admitted
episode data collected by a health insurer or funder. The time
between a related hospital admission and an offer to par-
ticipate in a DM program is a significant predictor, but in-
surers also should be concerned that there is an optimal time
period from offer to commencement. Better targeting of
health fund members with chronic disease for DM programs
is likely to reduce health insurance claims and hospitaliza-
tions. The efficiency of large-scale DM programs will be
improved with the implementation of population-based cri-
teria that are evidence-based, consistent, and transparent.
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